Monday, September 25, 2017
Tags Eli Lilly

Tag: Eli Lilly

Popular Articles

Black Bay Energy recapitalises SCS to expand product offerings

Black Bay Energy Capital has recapitalised SCS Technologies a provider of liquid production measurement equipment.

Trivest Partners smashes previous fundraise with sixth PE fund

Trivest Partners has raised $580.2m for its sixth private equity fund, according to an SEC filing, way above the figure raised in its previous fundraise.

Provasi Capital hires former WP Carey VP John Guthery

Provasi Capital Partners has hired ex-WP Carey senior vice president John Guthery as a managing director.

Platinum Equity considers launch of maiden small-cap fund

Platinum Equity is reportedly in talks with investors about launching its first small-cap fund.

Valiance continues medical tech investing surge with FEops backing

Private investment firm Valiance has led a €6m series B investment round in medical tech company FEops, along with existing investors Capricorn and PMV.

Fidelity, Accel, General Catalyst among those investing in Deliveroo’s $385m funding round

A whole host of private equity and venture capital firms have contributed to Deliveroo's latest funding round, raising $358m which values the company at over $2bn.

Arsenal Capital hires ex-Actis IR Patricia Grad after retirement of Bill Farrell

Arsenal Capital has recruited former Actis exec Patricia Grad as a senior managing director and head of investor relations after the retirement of longstanding...

Blue Wolf invests in StateServ Holdings weeks after launching new $525m fund

Healthcare-focused Blue Wolf Capital Partners has invested in medical equipment management services StateServ Holdings. The company offers management services to more than 550 hospice providers...

Littlejohn & Co exits C&K Holdings to Sun European Partners

Mid market PE firm Littlejohn & co has exited interface tech solutions company C&K Holdings to fellow buyout house Sun European Partners.

Avista Capital agrees Miraca Life Science carve-out from Japanese parent business

Avista Capital Partners has agreed to buy the life science operation of Japanese lab testing and clinical diagnostics business Miraca Holdings.